Crijns HJ - Search Results

1

Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.

van Wijk LM, Crijns HJ, Kingma HJ, van Gilst WH, van Gelder IC, Wesseling H, Lie KI. van Wijk LM, et al. Among authors: crijns hj. J Cardiovasc Pharmacol. 1990 Jun;15(6):884-91. J Cardiovasc Pharmacol. 1990. PMID: 1694910

2

Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.

Wiesfeld AC, Crijns HJ, Van Veldhuisen DJ, Van Gilst WH, Lie KI. Wiesfeld AC, et al. Among authors: crijns hj. Clin Cardiol. 1992 Sep;15(9):689-92. doi: 10.1002/clc.4960150912. Clin Cardiol. 1992. PMID: 1395204 Free article.

3

Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter.

Gosselink AT, Crijns HJ, Van Gelder IC, Hillige H, Wiesfeld AC, Lie KI. Gosselink AT, et al. Among authors: crijns hj. JAMA. 1992 Jun 24;267(24):3289-93. JAMA. 1992. PMID: 1597910 Clinical Trial.

4

Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.

Van Veldhuisen DJ, Crijns HJ, Girbes AR, Tobé TJ, Wiesfeld AC, Lie KI. Van Veldhuisen DJ, et al. Among authors: crijns hj. Am J Cardiol. 1991 Nov 1;68(11):1194-202. doi: 10.1016/0002-9149(91)90193-o. Am J Cardiol. 1991. PMID: 1683146

5

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.

Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Crijns HJ, et al. Am J Cardiol. 1991 Aug 1;68(4):335-41. doi: 10.1016/0002-9149(91)90828-9. Am J Cardiol. 1991. PMID: 1907089

6

Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter.

Van Gelder IC, Crijns HJ, Van der Laarse A, Van Gilst WH, Lie KI. Van Gelder IC, et al. Among authors: crijns hj. Am Heart J. 1991 Jan;121(1 Pt 1):51-6. doi: 10.1016/0002-8703(91)90954-g. Am Heart J. 1991. PMID: 1985377

7

Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.

Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Van Gelder IC, et al. Among authors: crijns hj. Am J Cardiol. 1991 Jul 1;68(1):41-6. doi: 10.1016/0002-9149(91)90707-r. Am J Cardiol. 1991. PMID: 2058558

8

Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation.

van Wijk LM, den Heijer P, Crijns HJ, van Gilst WH, Lie KI. van Wijk LM, et al. Among authors: crijns hj. J Cardiovasc Pharmacol. 1989 Jan;13(1):32-6. doi: 10.1097/00005344-198901000-00005. J Cardiovasc Pharmacol. 1989. PMID: 2468933 Clinical Trial.

9

Electrophysiological properties of isradipine (PN200-110) in humans.

van Wijk LM, van den Toren WE, van Gelder I, Crijns HJ, Ruegg P, Lie KI. van Wijk LM, et al. Among authors: crijns hj. J Cardiovasc Pharmacol. 1989 Sep;14(3):492-5. doi: 10.1097/00005344-198909000-00020. J Cardiovasc Pharmacol. 1989. PMID: 2476631

10

Effects of flecainide on the atrial defibrillation threshold.

Van Gelder IC, Crijns HJ, Van Gilst WH, De Langen CD, Van Wijk LM, Lie KI. Van Gelder IC, et al. Among authors: crijns hj. Am J Cardiol. 1989 Jan 1;63(1):112-4. doi: 10.1016/0002-9149(89)91090-4. Am J Cardiol. 1989. PMID: 2491771 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

819 results

Search Page

Filters